Emerging Stronger After COVID-19: Priorities for Health System Transformation
The National Academy of Medicine (NAM) published the first of a series of sector-by-sector reviews of the health care system identifying insights and opportunities for growth as the US emerges from the COVID-19 pandemic. The papers will be released periodically and then published as a bundle in the fall of 2021 as an NAM Special Publication.
A Look Ahead: AAMC 2021 Advocacy and Policy Priorities
In a new episode of the “Beyond the White Coat” podcast, David Skorton, MD, AAMC President and CEO, talks with guests about how the academic medicine community can educate lawmakers about the issues that will help their institutions continue to serve their patients and communities.
Research Recovery: Medicine’s Newest Scientists Restart Careers Stalled by COVID-19
This article from AAMCNews explores the unique challenges researchers face as they return to the lab under COVID-19 restrictions. In response, schools and some federal agencies are seeking ways to help early-career researchers make up for lost time.
Leveraging Open Science to Accelerate Research
In this New England Journal of Medicine perspectives piece, the authors present strategies policymakers could consider for incorporating “open-science principles into research policies and programs to optimize the return on federal investment in clinical research, which could have benefits beyond the pandemic.”
The Impact of the COVID-19 Pandemic on the Extramural Scientific Workforce: Outcomes from an NIH-Led Survey
This NIH blog highlighted key results from a survey of extramural researchers and administrators on the impact of the COVID-19 pandemic on the research workforce. Early-career researchers were most likely to be very concerned about their career trajectory.
Building Capacity for Economic Evaluation in Implementation Science
The National Cancer Institute (NCI) Implementation Science blog features the progress to date of a new working group that aims to identify critical aspects of including economic evaluations in implementation science. The working group, which includes implementation scientists, health services researchers, and economists, invites others to submit input about the needs the research community has related to this newly-emerging area of study.
Data Science in Clinical and Translational Research: Improving the Health of the Data to Knowledge Pipeline
This themed issue of the Journal of Clinical and Translational Science features a collection of manuscripts that highlight the diversity of innovations in data science relevant to translational researchers, including "integration of data science into clinical research, the growing demand for transparency and purpose behind clinical algorithms, and the increasing expectations of rigor and reproducibility of the data pipelines."
Academic Medicine Calls for Letters from Trainees
May 28 – Deadline for original submissions from trainees on the topic of “trainees as agents of change in academic medicine and the health professions.” Academic Medicine is looking for submissions that highlight actionable ways medical and health professions trainees can act as agents of change within the environments where they learn, work, and live. Letters can have up to three authors and all must be trainees.
GACD Implementation Science e-Hub
This collection of resources from the Global Alliance for Chronic Diseases (GACD) includes an implementation science reading list, a toolkit of helpful links and information from implementation science programs and organizations, and an online self-guided training program that provides an overview of basic principles for those new to the field.
AAMC Endorses Bill Addressing Social Determinants of Health
The AAMC endorsed the Social Determinants Accelerator Act (SDAA, H.R. 2503), which would address the nonmedical factors that affect health outcomes and can result in unfair, avoidable health inequities.
AAMC Comments on Release of President’s Proposal for Top-line FY 2022 Discretionary Funding
The AAMC issued a statement on President Joe Biden’s request for fiscal year (FY) 2022 discretionary funding. The proposal includes investments to advance medical research, combat the opioid epidemic, address health inequities and disparities, increase and diversify the nation’s health care workforce, and improve readiness for future public health crises.